SIME completes study validating clinical AI platform in RDS

World |  News | 0 Comment | 06 May, 2019

SIME, a Clinical AI company generating unique biological data to deliver life-saving solutions, announced the publication of its pivotal 'Fast Assessment of Lung Maturity at Birth' study. T...Read more

FBI approves Verogen's Next-Gen Forensic DNA technology for National DNA Index System

World |  News | 0 Comment | 06 May, 2019

Verogen Inc., the world’s first DNA sequencing company dedicated to forensic science has announced that the United States Federal Bureau of Investigation has approved the company&rsqu...Read more

FDA approves Genentech's Kadcyla

World |  News | 0 Comment | 06 May, 2019

Genentech, a member of the Roche Group has announced that the U.S. Food and Drug Administration (FDA) has approved Kadcyla (ado-trastuzumab emtansine) for adjuvant (after surgery) trea...Read more

Prima-Temp announces new leadership, investment and CE Mark certification

World |  News | 0 Comment | 03 May, 2019

Prima-Temp, Inc. a developer and manufacturer of AI-assisted fertility management products, has announced  that in March, it raised $5M in new funding from the Hungarian phar...Read more

DarioHealth partners with the American Diabetes Association

World |  News | 0 Comment | 03 May, 2019

Global digital therapeutics innovator, DarioHealth Corp. announced that it is partnering with the American Diabetes Association as a Living Red Sponsor of NYC - Step Out®: Walk to Stop ...Read more

NIH names Dr. Debara L. Tucci as the next director of NIDCD

World |  News | 0 Comment | 03 May, 2019

National Institutes of Health Director Francis S. Collins, M.D., Ph.D., has selected Debara L. Tucci, M.D., M.S., M.B.A., to lead the National Institute on Deafness and Other Communication ...Read more

binx health gets CE Mark for Rapid CT/NG test for mass markets

World |  News | 0 Comment | 02 May, 2019

binx health™, the pioneer in anywhere care has announced that its proprietary Chlamydia and Gonorrhea (CT/NG) test has received European CE Mark approval. The new multiplex test works...Read more

Agilent, SomaLogic sign agreement for supply of custom microarrays

World |  News | 0 Comment | 02 May, 2019

Agilent Technologies and  SomaLogic have announced a multi-year supply agreement whereby Agilent will supply customized high-fidelity oligo microarrays for use in the nucleic...Read more

FDA gives nod to first vaccine for dengue prevention

World |  News | 0 Comment | 02 May, 2019

The U.S. Food and Drug Administration has announced the approval of Dengvaxia, the first vaccine approved for the prevention of dengue disease caused by all dengue virus serotypes (1, 2, 3 ...Read more

CVS Health joins Quit big Tobacco campaign

World |  News | 0 Comment | 02 May, 2019

CVS Health, a US based premier health innovation company as well as the 7th largest company in the United States in terms of revenue, has pledged not to work with advertising...Read more

Abbott announces partnership with DoD

World |  News | 0 Comment | 03 May, 2019

Abbott has announced the next phase of partnership with the U.S. Department of Defense (DoD) and researchers from the Transforming Research and Clinical Knowledge in&nbs...Read more

NHS England partners with Gilead, Merck & AbbVie to eliminate Hep C

World |  News | 1 Comment | 01 May, 2019

The NHS will find and cure tens of thousands more people with hepatitis C as part of a ground-breaking deal that could help England become the first country in the world to eliminate the de...Read more

UN calls for urgent action to avert antimicrobial resistance crisis

World |  News | 0 Comment | 30 Apr, 2019

UN, international agencies and experts has released a groundbreaking report demanding immediate, coordinated and ambitious action to avert a potentially disastrous drug-resistance...Read more

Philips introduces VitalMinds to help reduce delirium in the ICU

World |  News | 0 Comment | 30 Apr, 2019

Royal Philips, a global leader in health technology has introduced VitalMinds, an integrated multi-component solution focused on supporting hospitals with a non-pharmacological approac...Read more

USFDA accepts NDA and grants priority review for Bayer’s darolutamide

World |  News | 0 Comment | 29 Apr, 2019

Bayer announced the U.S. Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) and granted Priority Review to darolutamide for the treatment of non-metastatic castr...Read more

IQVIA changing healthcare with AI, ML

World |  News | 0 Comment | 29 Apr, 2019

With IQVIA AI & machine learning, one can move with precision, speed and scale across every phase of a product’s lifecycle. These industry-leading technologies are driven by the t...Read more

ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD

World |  News | 0 Comment | 26 Apr, 2019

ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative medicines to address unmet medical needs in central nervous system (C...Read more

Illumina reports financial results for first quarter of FY 2019

World |  News | 0 Comment | 26 Apr, 2019

Illumina has announced its financial results for the first quarter of fiscal year 2019. First quarter 2019 results: Revenue of $846 million, an 8% increase compared to $782 million...Read more